Bausch Health Companies | VRX - Current Assets

Stock Price
8.21
Daily Change
-0.16 -1.91%
Monthly
3.14%
Yearly
-19.75%
Q1 Forecast
8.16

Bausch Health Companies reported $6.16B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Amgen USD 29.06B 1.17B Dec/2025
ANI Pharmaceuticals USD 698.4M 95.77M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Bausch Health Companies USD 6.16B 92M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025
Zoetis USD 6.77B 185M Dec/2025